Literature DB >> 21898344

Treatment of pediatric Erdheim-Chester disease with interleukin-1-targeting drugs.

T A Tran1, D Pariente, J C Lecron, A Delwail, Y Taoufik, U Meinzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21898344     DOI： 10.1002/art.30638

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  12 in total

Review 1.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

3.  Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease.

Authors:  Eli L Diamond; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Lynn Brody; Maria Arcila; Christian Bowers; Mark Fluchel
Journal:  Blood       Date:  2016-08-17       Impact factor: 22.113

Review 4.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2015-07-23       Impact factor: 7.580

5.  Erdheim Chester disease with appendicular skeletal, renal and pleural involvement responding to Zelboraf (BRAF inhibitor) treatment: case report.

Authors:  Dariusz Borys; Lucas Nystrom; Albert Song; Laurie M Lomasney
Journal:  Skeletal Radiol       Date:  2016-07-16       Impact factor: 2.199

6.  Erdheim-Chester disease with asymmetric talus involvement: A case report.

Authors:  Qin Xia; Cheng Tao; Ke-Wei Zhu; Wei-Ye Zhong; Peng-Lin Li; Yi Jiang; Min-Zhi Mao
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

7.  Diabetes insipidus, bone lesions, and new-onset red-brown papules in a 42-year-old man.

Authors:  Rachel I Kornik; Haley B Naik; Chyi-Chia Richard Lee; Juvianee Estrada-Veras; William A Gahl; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2013-03-01       Impact factor: 11.527

8.  Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment.

Authors:  Fréderic Franconieri; Samuel Deshayes; Hubert de Boysson; Salim Trad; Nicolas Martin Silva; Benjamin Terrier; Boris Bienvenu; Françoise Galateau-Sallé; Jean-François Emile; Alison C Johnson; Achille Aouba
Journal:  Oncoimmunology       Date:  2018-04-09       Impact factor: 8.110

9.  Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Anat Kesler; Orna Aizenstein; Iris Eshed; Ronald Jaffe; Yakov Pessach; Ilan Goldberg; Eli Sprecher; Iris Yaish; Alexander Gural; Chezi Ganzel; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2014-12-01       Impact factor: 8.775

Review 10.  Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.

Authors:  Ichiro Murakami; Michiko Matsushita; Takeshi Iwasaki; Satoshi Kuwamoto; Masako Kato; Keiko Nagata; Yasushi Horie; Kazuhiko Hayashi; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Jean Gogusev; Francis Jaubert; Katsuyoshi Takata; Takashi Oka; Tadashi Yoshino
Journal:  Cell Commun Signal       Date:  2015-02-22       Impact factor: 5.712
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.